T2 research reshapes a new thyroid metabolism formula
668. We Put T2 to the Test: The Research, Our Results, and the New Thyroid Fixxr
The episode weighs limited human evidence and a small trial against animal research to explain how T2 informed a new thyroid-support product.
- 1Animal studies link T2 with metabolism and fat browning, while human evidence remains limited.
- 2A 14-week trial involving 14 women produced findings shaped by differences in thyroid and hormone status.
- 3The results influenced dosing decisions for the new Thyroid Fixxr product.
Don't miss
Hornaman explains how results from the 14-week trial of 14 women, including differences in thyroid and hormone status, shaped Thyroid Fixxr’s dosing approach.
The brief
Dr. Amie Hornaman frames T2 as an overlooked thyroid hormone with possible relevance to metabolism, inflammation, elevated insulin, and insulin resistance.
The research picture is uneven: animal studies suggest effects on metabolism and fat browning, while limited human evidence links T2 with resting metabolic rate and body weight.
A 14-week trial involving 14 women becomes the episode’s practical test, with differences in thyroid and hormone status shaping how the results are interpreted.
Those findings inform the dosing approach for Thyroid Fixxr, turning the discussion from T2’s theoretical promise toward a specific product formulation.
Featuring
Amie Hornaman
ZepboundListen to the full episode and explore every guest, topic, and moment on PodLume.